Quipt Home Medical has recently issued a response to the updated acquisition proposal presented by Forager Capital Management, highlighting concerns about the nature and value of the bid. Forager Capital Management (FCM) proposed to acquire all issued and outstanding common shares of Quipt at $3.10 per share in cash, emphasizing the significant premium this offer represents over Quipt’s recent trading prices. The proposed transaction is underscored as a top priority for FCM, with intentions to proceed swiftly and potentially close within 16 weeks.
In contrast, Quipt disclosed that FCM’s current offer of $3.10 per share is lower than their previous proposal in January, where FCM offered $3.90 per share, reflecting a 26% increase. Quipt’s decision to decline FCM’s initial proposal in January was based on the belief that the offer undervalued the company by providing only a marginal premium to the market price at that time. The company emphasized the importance of ensuring any potential acquisition accurately reflects the current and future value of Quipt to uphold the interests of both the company and its shareholders.
Furthermore, Quipt raised doubts about FCM’s credibility, citing non-compliance with U.S. securities laws and lack of engagement through Quipt’s designated financial advisor. The company expressed concerns about FCM’s failure to adhere to the Non-Disclosure and Standstill Agreement and questioned the shareholder’s motives. While acknowledging the possibility of engaging with FCM on an amicable basis under a confidentiality agreement, Quipt emphasized the need for FCM to demonstrate genuine value creation for shareholders through any proposed bid.
Quipt’s response underscores the company’s commitment to safeguarding shareholder interests and ensuring that any potential acquisition accurately reflects the true value of the company. By highlighting discrepancies in FCM’s proposals and raising concerns about compliance and engagement, Quipt aims to maintain transparency and uphold best practices in the acquisition process. The company’s emphasis on engaging with FCM under a confidentiality agreement demonstrates a willingness to explore mutually beneficial agreements while prioritizing shareholder value and corporate integrity.
Key Takeaways:
– Quipt Home Medical responded to Forager Capital Management’s updated acquisition proposal, expressing concerns about the bid’s value and FCM’s compliance with securities laws.
– FCM’s offer of $3.10 per share was noted to be lower than their previous proposal of $3.90 per share in January, prompting Quipt to question the credibility and motives behind the current bid.
– Quipt emphasized the importance of any acquisition reflecting the true value of the company to protect shareholder interests and uphold corporate integrity.
– The company expressed a willingness to engage with FCM under a confidentiality agreement to explore potential bids that genuinely benefit shareholders and align with Quipt’s strategic objectives.
Read more on hmenews.com